Coukos G - Search Results

1

Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

Pétremand R, Chiffelle J, Bobisse S, Perez MAS, Schmidt J, Arnaud M, Barras D, Lozano-Rabella M, Genolet R, Sauvage C, Saugy D, Michel A, Huguenin-Bergenat AL, Capt C, Moore JS, De Vito C, Labidi-Galy SI, Kandalaft LE, Dangaj Laniti D, Bassani-Sternberg M, Oliveira G, Wu CJ, Coukos G, Zoete V, Harari A. Pétremand R, et al. Among authors: coukos g. Nat Biotechnol. 2024 Jun 25. doi: 10.1038/s41587-024-02318-9. Online ahead of print. Nat Biotechnol. 2024. PMID: 38918618 No abstract available.

2

Endothelin B receptor, a new target in cancer immune therapy.

Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Clin Cancer Res. 2009 Jul 15;15(14):4521-8. doi: 10.1158/1078-0432.CCR-08-0543. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567593 Free PMC article. Review.

3

The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Kandalaft LE, Singh N, Liao JB, Facciabene A, Berek JS, Powell DJ Jr, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Gynecol Oncol. 2010 Feb;116(2):222-33. doi: 10.1016/j.ygyno.2009.11.001. Epub 2009 Dec 2. Gynecol Oncol. 2010. PMID: 19959212 Free PMC article. Review.

4

Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin.

Kandalaft LE, Motz GT, Busch J, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Curr Top Microbiol Immunol. 2011;344:129-48. doi: 10.1007/82_2010_95. Curr Top Microbiol Immunol. 2011. PMID: 20680802 Review.

5

Immunotherapy for ovarian cancer: what's next?

Kandalaft LE, Powell DJ Jr, Singh N, Coukos G. Kandalaft LE, et al. Among authors: coukos g. J Clin Oncol. 2011 Mar 1;29(7):925-33. doi: 10.1200/JCO.2009.27.2369. Epub 2010 Nov 15. J Clin Oncol. 2011. PMID: 21079136 Free PMC article. Review.

6

Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance.

Kandalaft LE, Motz GT, Duraiswamy J, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Cancer Metastasis Rev. 2011 Mar;30(1):141-51. doi: 10.1007/s10555-011-9289-9. Cancer Metastasis Rev. 2011. PMID: 21298574 Review.

7

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.

Chiang CL, Kandalaft LE, Coukos G. Chiang CL, et al. Among authors: coukos g. Int Rev Immunol. 2011 Apr-Jun;30(2-3):150-82. doi: 10.3109/08830185.2011.572210. Int Rev Immunol. 2011. PMID: 21557641 Review.

8

Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate.

Chiang CL, Maier DA, Kandalaft LE, Brennan AL, Lanitis E, Ye Q, Levine BL, Czerniecki BJ, Powell DJ Jr, Coukos G. Chiang CL, et al. Among authors: coukos g. J Transl Med. 2011 Nov 14;9:198. doi: 10.1186/1479-5876-9-198. J Transl Med. 2011. PMID: 22082029 Free PMC article.

9

A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.

Kandalaft LE, Powell DJ Jr, Coukos G. Kandalaft LE, et al. Among authors: coukos g. J Transl Med. 2012 Aug 3;10:157. doi: 10.1186/1479-5876-10-157. J Transl Med. 2012. PMID: 22863016 Free PMC article. Clinical Trial.

10

Conference scene: Immune signatures in the tumor and beyond.

Kandalaft LE, Kalos M, Melief CJ, Speiser DE, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Immunotherapy. 2012 Aug;4(8):761-72. doi: 10.2217/imt.12.70. Immunotherapy. 2012. PMID: 22947003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters